Straits Times Index
3,394.21 +17.02 (+0.50%) Nikkei
27,382.56 +19.81 (+0.07%) Hang Seng
22,688.90 +122.12 (+0.54%) FTSE 100
7,765.15 +4.04 (+0.05%) BTC-USD
23,083.90 +56.50 (+0.25%) CMC Crypto 200
526.66 +9.65 (+1.87%)
VRTX Jan 2024 290.000 put
| Previous close | 20.80 |
| Open | 19.30 |
| Bid | 13.80 |
| Ask | 21.60 |
| Strike | 290.00 |
| Expiry date | 2024-01-19 |
| Day's range | 19.30 - 19.30 |
| Contract range | N/A |
| Volume | |
| Open interest | 63 |
- Motley Fool
The Best Stocks to Invest $20,000 in Right Now
Companies in the healthcare industry in particular are often known for producing steady performance even in a tough macro period as they aren't exposed to the same economic cyclicality that other industries are. Vertex Pharmaceuticals (NASDAQ: VRTX) is a healthcare company that specializes in medicines and therapies targeting rare diseases. Right now, the company's approved medicines are all for the rare genetic disease cystic fibrosis, and it controls the lion's share of this multibillion-dollar market with its four products that treat the ailment.
- Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
If you want solid healthcare stocks that will be worth buying and holding for the next 10 years, you need to set the bar pretty high. But thanks to its portfolio and late-stage pipeline therapies, its next few years should feature strong growth.
- Zacks
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $313.57, marking a +0.56% move from the previous day.
